Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Povidone K25 Eye Drops in Healthy Volunteers
NCT00135824Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2004
- Primary completion
- May 2004
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in dry eye syndrome (DED) comparing Povidone K25 with Placebo (2 arms). Primary endpoint: Ocular Discomfort by Visual Analogue Scale (VAS). Started Mar 2004; status: completed.
02
Drugs
povidone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00135824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135824.